Replies to post #214385 on Biotech Values

[DewDiligence]

ABT 3Q17 sales by business segment:

 Medical devices  39%   
 Nutrition        26%   
 Diagnostics      20%   
 Pharmaceuticals† 15% 

66% of overall sales were ex-US.

†Ex-US branded generics.